Hussman Strategic Advisors, Inc. Roivant Sciences Ltd. Transaction History
Hussman Strategic Advisors, Inc.
- $351 Million
- Q2 2024
A detailed history of Hussman Strategic Advisors, Inc. transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Hussman Strategic Advisors, Inc. holds 105,000 shares of ROIV stock, worth $1.19 Million. This represents 0.32% of its overall portfolio holdings.
Number of Shares
105,000
Previous 105,000
-0.0%
Holding current value
$1.19 Million
Previous $1.11 Million
0.27%
% of portfolio
0.32%
Previous 0.27%
Shares
1 transactions
Others Institutions Holding ROIV
# of Institutions
308Shares Held
496MCall Options Held
989KPut Options Held
1.15M-
Sb Investment Advisers (Uk) LTD London, X071.4MShares$811 Million6.97% of portfolio
-
Viking Global Investors LP69.2MShares$786 Million2.91% of portfolio
-
Qvt Financial LP New York, NY66.7MShares$759 Million72.99% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$402 Million0.01% of portfolio
-
Morgan Stanley New York, NY29.3MShares$333 Million0.02% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.01B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...